Chie Oshita

534 total citations
10 papers, 372 citations indexed

About

Chie Oshita is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Chie Oshita has authored 10 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Chie Oshita's work include Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and T-cell and B-cell Immunology (4 papers). Chie Oshita is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and T-cell and B-cell Immunology (4 papers). Chie Oshita collaborates with scholars based in Japan and United States. Chie Oshita's co-authors include Yasuto Akiyama, Tadashi Ashizawa, Akira Iizuka, Akiko Kume, Haruo Miyata, Masaru Komiyama, Ken Yamaguchi, Yoko Nakasu, Koichi Mitsuya and Takashi Sugino and has published in prestigious journals such as BMC Cancer, Cancer Science and Cancer Immunology Immunotherapy.

In The Last Decade

Chie Oshita

10 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chie Oshita Japan 7 217 192 185 58 48 10 372
Jonathan S. George United States 6 154 0.7× 77 0.4× 115 0.6× 73 1.3× 85 1.8× 7 471
Roger S. Chen Switzerland 6 182 0.8× 76 0.4× 304 1.6× 69 1.2× 64 1.3× 6 543
Filippo Spriano Switzerland 13 161 0.7× 43 0.2× 320 1.7× 54 0.9× 53 1.1× 43 513
Nobuaki Amino Japan 9 208 1.0× 93 0.5× 242 1.3× 14 0.2× 58 1.2× 14 457
Mugdha Velankar United States 4 282 1.3× 69 0.4× 718 3.9× 47 0.8× 68 1.4× 7 863
Soraya Wuillème‐Toumi France 5 151 0.7× 75 0.4× 467 2.5× 37 0.6× 19 0.4× 6 553
Steve W. Elmore United States 3 179 0.8× 46 0.2× 369 2.0× 39 0.7× 32 0.7× 4 437
Siddhartha Sen United States 11 106 0.5× 90 0.5× 284 1.5× 18 0.3× 14 0.3× 15 410
Nga T. Dai United States 8 198 0.9× 65 0.3× 418 2.3× 61 1.1× 10 0.2× 8 519
Timothy C. Hancox United Kingdom 6 239 1.1× 230 1.2× 233 1.3× 106 1.8× 153 3.2× 6 597

Countries citing papers authored by Chie Oshita

Since Specialization
Citations

This map shows the geographic impact of Chie Oshita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chie Oshita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chie Oshita more than expected).

Fields of papers citing papers by Chie Oshita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chie Oshita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chie Oshita. The network helps show where Chie Oshita may publish in the future.

Co-authorship network of co-authors of Chie Oshita

This figure shows the co-authorship network connecting the top 25 collaborators of Chie Oshita. A scholar is included among the top collaborators of Chie Oshita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chie Oshita. Chie Oshita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Iizuka, Akira, Masaru Komiyama, Chie Oshita, et al.. (2014). Anti-vascular endothelial growth factor receptor (VEGFR) 2 autoantibody identification in glioblastoma patient using single B cell-based antibody gene cloning. Immunology Letters. 159(1-2). 15–22. 6 indexed citations
2.
Akiyama, Yasuto, Tadashi Ashizawa, Masaru Komiyama, et al.. (2014). YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line. Oncology Reports. 32(1). 159–166. 33 indexed citations
3.
Akiyama, Yasuto, Masaru Komiyama, Haruo Miyata, et al.. (2014). Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients. Oncology Reports. 31(4). 1683–1690. 23 indexed citations
4.
Akiyama, Yasuto, Haruo Miyata, Masaru Komiyama, et al.. (2014). The identification of affinity peptide ligands specific to the variable region ofhuman antibodies. Biomedical Research. 35(2). 105–116. 5 indexed citations
5.
Oshita, Chie, Akiko Kume, Haruo Miyata, et al.. (2012). Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial. Oncology Reports. 28(4). 1131–1138. 83 indexed citations
6.
Akiyama, Yasuto, Masaru Komiyama, Yoji Nakamura, et al.. (2012). Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay. Cancer Immunology Immunotherapy. 61(12). 2311–2319. 18 indexed citations
7.
Akiyama, Yasuto, Chie Oshita, Akiko Kume, et al.. (2012). α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial. BMC Cancer. 12(1). 623–623. 70 indexed citations
8.
Nakamura, Yoji, Sachiko Tai, Chie Oshita, et al.. (2011). Analysis of HLA‐A24‐restricted peptides of carcinoembryonic antigen using a novel structure‐based peptide‐HLA docking algorithm. Cancer Science. 102(4). 690–696. 6 indexed citations
9.
Iizuka, Akira, Masaru Komiyama, Sachiko Tai, et al.. (2010). Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients. Immunology Letters. 135(1-2). 64–73. 7 indexed citations
10.
Matsuno, Kenji, Yoshiaki Masuda, Yutaka Uehara, et al.. (2010). Identification of a New Series of STAT3 Inhibitors by Virtual Screening. ACS Medicinal Chemistry Letters. 1(8). 371–375. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan S. George Breakdown of academic impact, for papers by Roger S. Chen Breakdown of academic impact, for papers by Filippo Spriano Breakdown of academic impact, for papers by Nobuaki Amino Breakdown of academic impact, for papers by Mugdha Velankar Breakdown of academic impact, for papers by Soraya Wuillème‐Toumi Breakdown of academic impact, for papers by Steve W. Elmore Breakdown of academic impact, for papers by Siddhartha Sen Breakdown of academic impact, for papers by Nga T. Dai Breakdown of academic impact, for papers by Timothy C. Hancox
Rankless by CCL
2026